INIVATA IS A LEADER
IN LIQUID BIOPSY
Lung Cancer Awareness Month
We are transforming the lives of cancer patients and their families through the power of liquid biopsy
Latest News and Events
Inivata and the European Organisation for Research and Treatment of Cancer (EORTC) collaborate in Phase II NSCLC study
Inivata to provide ctDNA liquid biopsy using its InVisionFirst®-Lung test to analyze resistance in patients treated with lorlatinib ... Read More
Clinical Utility of ctDNA Driver Genomic Alterations (GA) Directing Targeted Therapy in Untreated Advanced NSCLC Patients
L. Mezquita, D. Planchard, M. Dorta, M. Aldea, C. Naltet, V. Lamberts, A.-M. Grecea, P. Martin-Romano, F. de Kievit, C. Jovelet, E. ... Read More
Patients are at the heart of everything we do.
Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives.
This is the story of the first patient Inivata tested.